Post Misrepresents Details of Postmortem Study of Vaccinated Patient
SciCheck Digest
A controversial radio show host and blogger misrepresented findings of a published case report to conclude that an 86-year-old man died as a result of being vaccinated against COVID-19. The case report’s lead author said the man died of bacterial pneumonia and “there was not any sign of vaccination side effect.”
All of the authorized vaccines are effective at preventing symptomatic disease.
According to the results of the phase 3 trials, the Pfizer/BioNTech and Moderna vaccines had an efficacy of 94% or higher, which means your approximate risk of getting sick is cut by 94% or more if you are vaccinated. It’s important to keep in mind that the effectiveness of the vaccines outside the controlled setting of a clinical trial is typically somewhat lower. A study by the Centers for Disease Control and Prevention found these two vaccines were 90% effective in real-world conditions, two weeks after the second dose, and 80% effective two weeks after the first dose. The study monitored 3,950 health care personnel, first responders and other essential workers for 13 weeks.
Johnson & Johnson’s phase 3 trial began in , nearly two months after the Pfizer and Moderna trials and shortly before a new variant of the coronavirus in South Africa. Globally, J&J an efficacy of 66.1% in preventing moderate to severe COVID-19 and an efficacy of 85.4% in preventing severe or critical
You’re reading a preview, subscribe to read more.
Start your free 30 days